Sort
15,842 grants matching “pancreatic cancer”
Palliative Care Interventions for Outpatients Newly Diagnosed with Lung Cancer: Phase II
$0Lynn F Reinke · Va Puget Sound Healthcare System · IK3 · FY2020 · VA
ShEEP Request for NanoString nCounter® FLEX Analysis System
$0Khalil Ahmed · Minneapolis Va Medical Center · IS1 · FY2018 · VA
PILOT--GASTROINTESTINAL ONCOLOGY
$0University Of Michigan At Ann Arbor · P30 · FY2002 · CA
Palliative Care Interventions for Outpatients Newly Diagnosed with Lung Cancer: Phase II
$0Lynn F Reinke · Va Puget Sound Healthcare System · IK3 · FY2020 · VA
The role of the androgen receptor in insulin secretion
$0Franck Mauvais-Jarvis · Southeast Louisiana Veterans Health Care · I01 · FY2020 · VA
Phase II Study of Rapamycin in Pancreatic Cancer
$0Johns Hopkins University · R01 · FY2004 · FD
Inhibition of Angiogenesis by Thrombospondin-1
$0Beth Israel Deaconess Medical Center · P01 · FY2002 · CA
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance
$0Eileen S Carpenter · Veterans Health Administration · IK2 · FY2024 · VA
Molecular Mechanisms of Muscle and Fat Wasting in Pancreatic Cancer Cachexia
$0Teresa A Zimmers · Rlr Va Medical Center · I01 · FY2021 · VA
CORE--HUMAN TISSUE RESOURCE AND LOGISTICS
$0Johns Hopkins University · P50 · FY2001 · CA
Novel Reg4-CD44 Signaling Pathway in Colon Cancer
$0Brian Keith Dieckgraefe · St. Louis Va Medical Center · I01 · FY2018 · VA
BLR&D Research Career Scientist Award Application
$0Qizhi C. Yao · Michael E Debakey Va Medical Center · IK6 · FY2025 · VA
OXIDATIVE DAMAGE IN PANCREATITIS AND PANCREATIC NEOPLASIA
$0Fred Hutchinson Cancer Research Center · P01 · FY2002 · CA
DOSE ESCALATION TRIAL OF 100AA SYNTHETIC MUCIN PEPTIDE PANCREATIC CANCER
$0University Of Pittsburgh At Pittsburgh · M01 · FY2002 · RR
Gender-specific differences in disease susceptibility
$0Child Health And Human Development · Z01 · FY2003 · HD
Mechanisms of pharmacological ascorbate inhibition of pancreatic cancer metastases
$0Joseph J Cullen · Iowa City Va Medical Center · I01 · FY2018 · VA
MARKERS FOR RISK IN FAMILIAL PANCREATIC CANCER
$0Johns Hopkins University · P50 · FY2001 · CA
DENDRITIC CELLS--A NEW TUMOR ANTIGEN DISCOVERY SYSTEM
$0University Of Pittsburgh At Pittsburgh · P01 · FY2002 · CA
ISIS 5132 (CGP 69846A),C RAF ANTISENSE IN PANCREATIC CANCER PATIENTS
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2001 · RR
Novel Reg4-CD44 Signaling Pathway in Colon Cancer
$0Brian Keith Dieckgraefe · St. Louis Va Medical Center · I01 · FY2019 · VA
ShEEP Request for CTL ImmunoSpot S6 Universal Analyzer
$0Chinthalapally V. Rao · Oklahoma City Va Medical Center · IS1 · FY2019 · VA
TREATING ADVANCED PANCREATIC CANCER WITH OPIOID GROWTH FACTOR, PHASE I
$0Pennsylvania State Univ Hershey Med Ctr · M01 · FY2002 · RR
PERILLYL ALCOHOL IN RESECTABLE PANCREATIC CANCER
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2001 · RR
ShEEP request for Laser Capture Microdissection (LCM)
$0Jack B Longley · Wm S. Middleton Memorial Veterans Hosp · IS1 · FY2018 · VA
CORE--DNA DAMAGE AND MUTAGENESIS
$0Fred Hutchinson Cancer Research Center · P01 · FY2002 · CA